A retrospective study to assess impact of three-monthly palmitate paliperidone use characteristics, treatment persistence and evolution of pharmacological co-treatments in real-world settings
Latest Information Update: 15 Oct 2020
Price :
$35 *
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms SNIIR-AM cohort
- 15 Oct 2020 New trial record
- 15 Sep 2020 Results presented at the 33rd Annual Congress of the European College of Neuropsychopharmacology